US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 5.950
  • -0.050-0.83%
Close Apr 16 16:00 ET
  • 5.940
  • -0.010-0.17%
Post 19:40 ET
1.71BMarket Cap-17.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies (TSHA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.61%-93.09M
-45.96%-26.72M
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
Net income from continuing operations
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
Operating gains losses
7,593.75%1.2M
986.75%736K
489.33%292K
240.00%273K
-130.27%-102K
-100.04%-16K
99.87%-83K
---75K
---195K
--337K
Depreciation and amortization
-8.03%1.15M
-1.64%299K
-2.72%286K
-13.98%277K
-12.92%283K
-9.19%1.25M
-16.94%304K
-11.18%294K
-6.12%322K
-1.81%325K
Other non cash items
311.24%5.63M
1,113.09%3.64M
-51.13%673K
197.17%734K
461.90%590K
-86.48%1.37M
-113.92%-359K
-55.09%1.38M
-93.92%247K
-75.47%105K
Change In working capital
56.92%-5.37M
-171.90%-7.07M
168.53%4.03M
151.99%2.23M
-1,628.86%-4.56M
30.79%-12.47M
46.35%-2.6M
20.20%-5.88M
-437.94%-4.28M
105.96%298K
-Change in prepaid assets
-937.68%-1.73M
-360.68%-2.14M
231.04%971K
-41.36%482K
-51.80%-1.05M
-96.56%207K
-59.11%819K
-121.18%-741K
-9.57%822K
-73.25%-693K
-Change in payables and accrued expense
241.35%6.14M
139.20%548K
191.26%3.06M
193.44%3.73M
-127.31%-1.2M
49.36%-4.34M
56.94%-1.4M
45.25%-3.35M
-678.55%-3.99M
3,938.53%4.4M
-Change in other working capital
-17.28%-9.77M
-171.27%-5.49M
--0
-78.60%-1.99M
32.51%-2.3M
46.07%-8.33M
43.90%-2.02M
62.33%-1.79M
53.57%-1.11M
27.52%-3.41M
Cash from discontinued investing activities
Operating cash flow
-14.61%-93.09M
-45.96%-26.72M
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
Investing cash flow
Cash flow from continuing investing activities
-66.39%-604K
-2,000.00%-247K
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
Net PPE purchase and sale
-97.33%-738K
-12,600.00%-250K
-208.57%-108K
99.00%-2K
-170.00%-378K
90.33%-374K
111.76%2K
---35K
-518.75%-201K
96.41%-140K
Net intangibles purchase and sale
----
----
----
----
----
--0
--0
----
----
----
Net other investing changes
1,118.18%134K
--3K
--60K
--64K
--7K
-35.29%11K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-66.39%-604K
-2,000.00%-247K
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
Financing cash flow
Cash flow from continuing financing activities
258.08%274.59M
13,981.23%49.56M
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
Net issuance payments of debt
--9.24M
--0
----
----
----
--0
--0
----
----
----
Net common stock issuance
244.24%264.31M
13,597.22%48.59M
-106.82%-454K
----
----
-45.46%76.78M
14.89%-360K
-95.27%6.66M
----
----
Proceeds from stock option exercised by employees
1,449.44%1.38M
2,657.50%1.02M
172.82%281K
--0
188.46%75K
30.88%89K
---40K
472.22%103K
--0
-48.00%26K
Net other financing activities
-82.16%-337K
-232.56%-57K
-62.28%-271K
1,007.69%118K
-164.58%-127K
81.77%-185K
111.47%43K
-72.16%-167K
89.43%-13K
88.57%-48K
Cash from discontinued financing activities
Financing cash flow
258.08%274.59M
13,981.23%49.56M
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
Net cash flow
Beginning cash position
-3.35%141.64M
87.13%299.94M
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
61.89%146.54M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
Current changes in cash
3,788.72%180.9M
221.10%22.59M
-2.40%-15.42M
302.29%196.17M
-12.44%-22.44M
-108.75%-4.9M
8.46%-18.65M
-112.63%-15.06M
365.85%48.76M
18.38%-19.96M
End cash Position
127.72%322.53M
127.72%322.53M
87.13%299.94M
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
-3.35%141.64M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
Free cash flow
-14.99%-93.83M
-47.34%-26.97M
-12.12%-24.27M
7.01%-20.18M
-12.34%-22.4M
-1.51%-81.6M
-13.46%-18.31M
-0.94%-21.65M
-15.95%-21.71M
17.22%-19.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.61%-93.09M-45.96%-26.72M-11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M
Net income from continuing operations -22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M
Operating gains losses 7,593.75%1.2M986.75%736K489.33%292K240.00%273K-130.27%-102K-100.04%-16K99.87%-83K---75K---195K--337K
Depreciation and amortization -8.03%1.15M-1.64%299K-2.72%286K-13.98%277K-12.92%283K-9.19%1.25M-16.94%304K-11.18%294K-6.12%322K-1.81%325K
Other non cash items 311.24%5.63M1,113.09%3.64M-51.13%673K197.17%734K461.90%590K-86.48%1.37M-113.92%-359K-55.09%1.38M-93.92%247K-75.47%105K
Change In working capital 56.92%-5.37M-171.90%-7.07M168.53%4.03M151.99%2.23M-1,628.86%-4.56M30.79%-12.47M46.35%-2.6M20.20%-5.88M-437.94%-4.28M105.96%298K
-Change in prepaid assets -937.68%-1.73M-360.68%-2.14M231.04%971K-41.36%482K-51.80%-1.05M-96.56%207K-59.11%819K-121.18%-741K-9.57%822K-73.25%-693K
-Change in payables and accrued expense 241.35%6.14M139.20%548K191.26%3.06M193.44%3.73M-127.31%-1.2M49.36%-4.34M56.94%-1.4M45.25%-3.35M-678.55%-3.99M3,938.53%4.4M
-Change in other working capital -17.28%-9.77M-171.27%-5.49M--0-78.60%-1.99M32.51%-2.3M46.07%-8.33M43.90%-2.02M62.33%-1.79M53.57%-1.11M27.52%-3.41M
Cash from discontinued investing activities
Operating cash flow -14.61%-93.09M-45.96%-26.72M-11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M
Investing cash flow
Cash flow from continuing investing activities -66.39%-604K-2,000.00%-247K-37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K
Net PPE purchase and sale -97.33%-738K-12,600.00%-250K-208.57%-108K99.00%-2K-170.00%-378K90.33%-374K111.76%2K---35K-518.75%-201K96.41%-140K
Net intangibles purchase and sale ----------------------0--0------------
Net other investing changes 1,118.18%134K--3K--60K--64K--7K-35.29%11K----------------
Cash from discontinued investing activities
Investing cash flow -66.39%-604K-2,000.00%-247K-37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K
Financing cash flow
Cash flow from continuing financing activities 258.08%274.59M13,981.23%49.56M33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K
Net issuance payments of debt --9.24M--0--------------0--0------------
Net common stock issuance 244.24%264.31M13,597.22%48.59M-106.82%-454K---------45.46%76.78M14.89%-360K-95.27%6.66M--------
Proceeds from stock option exercised by employees 1,449.44%1.38M2,657.50%1.02M172.82%281K--0188.46%75K30.88%89K---40K472.22%103K--0-48.00%26K
Net other financing activities -82.16%-337K-232.56%-57K-62.28%-271K1,007.69%118K-164.58%-127K81.77%-185K111.47%43K-72.16%-167K89.43%-13K88.57%-48K
Cash from discontinued financing activities
Financing cash flow 258.08%274.59M13,981.23%49.56M33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K
Net cash flow
Beginning cash position -3.35%141.64M87.13%299.94M79.85%315.36M-5.84%119.19M-3.35%141.64M61.89%146.54M-3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M
Current changes in cash 3,788.72%180.9M221.10%22.59M-2.40%-15.42M302.29%196.17M-12.44%-22.44M-108.75%-4.9M8.46%-18.65M-112.63%-15.06M365.85%48.76M18.38%-19.96M
End cash Position 127.72%322.53M127.72%322.53M87.13%299.94M79.85%315.36M-5.84%119.19M-3.35%141.64M-3.35%141.64M-3.97%160.29M267.44%175.34M91.61%126.58M
Free cash flow -14.99%-93.83M-47.34%-26.97M-12.12%-24.27M7.01%-20.18M-12.34%-22.4M-1.51%-81.6M-13.46%-18.31M-0.94%-21.65M-15.95%-21.71M17.22%-19.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -